The weekly litigation news digest is live. Subscribe now

IP Verse

Antitumor Agent And Antitumor Effect Enhancer - EP3042669

The patent EP3042669 was granted to Taiho Pharmaceutical on Mar 8, 2023. The application was filed on Sep 5, 2014 under application number EP14842538A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3042669

TAIHO PHARMACEUTICAL
Application Number
EP14842538A
Filing Date
Sep 5, 2014
Status
Granted And Under Opposition
Feb 3, 2023
Publication Date
Mar 8, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GENERICS UKDec 7, 2023TER MEER STEINMEISTER & PARTNERADMISSIBLE
CAMULONNov 29, 2023REDDIE & GROSEADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO9630346
INTERNATIONAL-SEARCH-REPORTWO2014157443
INTERNATIONAL-SEARCH-REPORTWO2014157444
OPPOSITIONEP1849470
OPPOSITIONWO2015034032

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents